DiagnosisNCT07328815
Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning Using Behavioral Nudges
A study testing Behavioral Nudge Intervention in people with Diagnosis, run by Lahore University of Management Sciences at 1 site in Pakistan.
Trial summary
The goal of this randomized controlled trial is to evaluate whether behavioral nudges can reduce automation bias, the uncritical acceptance of automated output, in physicians using large language models (LLM) like ChatGPT-5.1 for clinical decision-making. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Diagnosis
- What is being tested?
- Behavioral Nudge Intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 72 participants
- Where
- 1 sitePakistan
- Study dates
- 17 Jan 2026to 26 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Full or Provisionally Registered Medical Practitioners with the Pakistan Medical and Dental Council (PMDC).
- Completed Bachelor of Medicine, Bachelor of Surgery (MBBS) Exam. The equivalent degree of MBBS in US and Canada is the Doctor of Medicine (MD).
- Participants must have completed a structured training program on the use of ChatGPT (or a comparable large language model), totaling at least 10 hours of instruction. The program must include hands-on practice related to LLM's key aspects, specifically prompt engineering and content evaluation.
Who cannot join
- Any other Registered Medical Practitioners (Full or Provisional) with PMDC (e.g., professionals with Bachelor of Dental Surgery or BDS).
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Lahore University of Management Sciences
Lahore, Punjab Province, 54792
About this study
The goal of this randomized controlled trial is to evaluate whether behavioral nudges can reduce automation bias, the uncritical acceptance of automated output, in physicians using large language models (LLM) like ChatGPT-5.1 for clinical decision-making.
The main question it aims to answer is: Does a dual-mechanism behavioral nudge intervention (baseline accuracy anchoring plus case-specific color-coded confidence signals) reduce physicians' uncritical acceptance of incorrect LLM recommendations?
Read more
Researchers will compare physicians who receive LLM recommendations along with a behavioral nudge to those who receive LLM recommendations without the nudge to assess if the nudge reduces automation bias.
Participants will:
- Evaluate six clinical vignettes accompanied by LLM-generated recommendations (half containing deliberate, clinically significant errors).
- Control group: Be able to view LLM recommendations in standard format without the nudge.
- Treatment group: Be able to view ChatGPT's diagnostic accuracy on standard medical datasets as an initial anchor, then receive color-coded confidence signals alongside each recommendation (e.g., red for low confidence).
- Have their responses evaluated by blinded reviewers using an expert-developed assessment rubric to detect uncritical acceptance of erroneous information.
Read the detailed description
Automation bias represents a critical challenge in modern clinical practice, particularly as artificial intelligence (AI) tools become increasingly embedded in healthcare workflows. This cognitive phenomenon describes the tendency of clinicians to favor suggestions from automated decision-making systems, even when those suggestions are incorrect. As Large Language Models (LLM) such as ChatGPT-5.1 gain traction in medical settings, their potential to reduce errors and improve efficiency must be weighed against a significant concern: these models lack rigorous medical validation and may amplify existing cognitive biases through incorrect or misleading recommendations.
The emergence of automation bias in medical contexts reflects a complex interplay of environmental and psychological factors. Time constraints in high-volume clinical settings create pressure to accept AI-generated recommendations without adequate scrutiny. Financial incentives that prioritize efficiency over thoroughness may further discourage critical evaluation necessary for sound clinical judgment. Cognitive fatigue during extended shifts diminishes physicians' capacity for sustained analytical thinking. These pressures interact with psychological mechanisms including diffusion of responsibility, overconfidence in technological solutions, and cognitive offloading, collectively creating conditions where uncritical acceptance of AI-generated recommendations becomes more likely.
This randomized controlled trial evaluates the effectiveness of a behavioral nudge intervention designed to mitigate automation bias among medical doctors utilizing LLM-generated diagnostic recommendations. The primary objective is to determine whether this intervention improves diagnostic reasoning performance scores when evaluating clinical vignettes that include deliberately flawed LLM recommendations. Secondary objectives include assessing whether physician experience level, gender, and prior LLM experience moderate the intervention's effectiveness, determining differential effectiveness for vignettes across different confidence signals.
This study employs a single-blind, randomized controlled trial with two parallel arms. Participants will be randomly assigned 1:1 to either the intervention or control arm. To eliminate variability from differences in prompting skills, participants will not interact directly with a live LLM interface. Instead, all participants will use a custom-built web platform displaying clinical vignettes with pre-generated LLM recommendations, ensuring identical LLM-generated content for each vignette.
All participants will evaluate six clinical vignettes during a single, proctored session lasting approximately 75 minutes. Three vignettes will contain deliberately introduced clinical reasoning flaws in the LLM recommendations, while three will contain correct recommendations. Vignettes will be presented in randomized order to prevent pattern detection.
Control arm participants will evaluate clinical vignettes with LLM diagnostic recommendations generated by ChatGPT presented in standard, neutral text format without additional contextual information. Intervention arm participants will evaluate the same vignettes alongside a behavioral nudge. This intervention consists of two synchronized cognitive cues: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the interface panel, explicitly anchoring expectations to the model's fallibility, and (2) a selective attention cue displaying the LLM recommendation alongside a color-coded confidence signal generated through an ensemble assessment: three independent state-of-the-art LLMs (Claude Sonnet 4.5, Gemini 2.5 Pro Thinking, and GPT-5.1) each provide confidence ratings for the recommendation, and the mean confidence determines the signal color to mitigate single-model miscalibration.
The color-coded confidence signals are categorized into three distinct levels based on the ensemble's mean confidence relative to baseline diagnostic accuracy. Red signals are triggered when the mean confidence falls below ChatGPT's established baseline accuracy, explicitly flagging high-uncertainty cases that demand heightened critical scrutiny. Orange signals indicate that while the mean confidence exceeds the baseline average, it remains below 100%, signaling the need for continued clinical vigilance and the avoidance of complacency. Finally, green signals are reserved for instances of 100% ensemble consensus; however, even at this level of confidence, standard AI safety warnings remain present to guard against over-reliance on the system's output.
Participants will be presented with six clinical vignettes specifically designed to measure automation bias, sourced and modified from real cases representing a range of diagnostic difficulty and common medical specialties. Each vignette follows a standardized format including chief complaint, history of present illness, relevant past medical/social/family history, physical examination findings, and initial laboratory results.
The primary outcome is the Diagnostic Reasoning Performance Score, a composite percentage score based on a structured rubric evaluating: quality of differential diagnoses, supporting findings, opposing findings, final diagnosis accuracy, and appropriateness of next steps. Secondary outcomes include top-choice diagnosis accuracy (incorrect, partially correct, or correct). All responses will be evaluated by blinded reviewers using the assessment rubric.
- Conditions
- Diagnosis
- Being tested
- Behavioral Nudge Intervention
- Keywords
- clinical reasoning, automation bias, behavioral nudges, computer-assisted diagnosis, large language models
- Medical subject headings
- Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Behavioral Nudge InterventionOther
Participants in the treatment group will receive a behavioral nudge intervention embedded in the LLM recommendations interface that presents two synchronized cognitive cues when the LLM panel is expanded: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the panel to set realistic expectations before viewing the specific recommendation, and (2) a selective attention cue located immediately below, which shows the LLM recommendation alongside a case-specific and color-coded confidence signal. This signal is categorized as red when the mean ensemble confidence falls below the established baseline accuracy, flagging high-uncertainty cases that demand critical evaluation; orange when confidence meets or exceeds the baseline but remains below 100%, intended to prevent complacency and maintain active clinical scrutiny; and green for a 100% ensemble consensus, though standard cautionary warnings still apply to guard against.
| Study group | Role | What they receive |
|---|---|---|
| ChatGPT Recommendations alongside a Behavioral Nudge | Active comparator | Participants will evaluate six clinical vignettes. During the trial, they will have access to clinical recommendations from a specific, commercially available LLM (ChatGPT) in addition to conventional diagnostic resources. LLM recommendations for three vignettes will contain deliberately flawed diagnostic information and for three vignettes it will contain accurate recommendations). The cases will be presented in random order. Participants in this arm will receive a behavioral nudge embedded in the LLM recommendations interface that presents two synchronized cognitive cues when the LLM panel is expanded: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the panel to set realistic expectations before cue intervention located immediately below, which shows the LLM recommendations alongside a case-specific color-coded confidence signal. Receives: Other: Behavioral Nudge Intervention |
| ChatGPT Recommendations without a Behavioral Nudge | No intervention | Participants will evaluate six clinical vignettes. During the trial, they will have access to clinical recommendations from a specific, commercially available LLM (ChatGPT) in addition to conventional diagnostic resources. LLM recommendations for three vignettes will contain deliberately flawed diagnostic information. The cases will be presented in random order. Participants in this arm will not receive any behavioral nudge. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Diagnostic reasoning accuracy score
The primary outcome will be the percent correct for each case, ranging from 0 to 100%, where higher scores indicate better diagnostic performance. For each case, participants will be asked for their three leading diagnoses, findings that support each diagnosis, and findings that oppose each diagnosis. For each plausible diagnosis, participants will receive 1 point. Findings supporting the diagnosis and findings opposing the diagnosis will also be graded based on correctness, with 1 point for each correct response. Participants will then be asked to name their top diagnosis they believe is most likely, earning 9 points for a reasonable response and 18 points for the most accurate response. Finally participants will be asked to name up to 3 next steps to further evaluate the patient with 0.5 point awarded for a partially correct response and 1 point for a completely correct response. The primary outcome will be compared at the case-level between the randomized groups.
Measured: Assessed at a single time point for each case, during the scheduled diagnostic reasoning evaluation session, which takes place between 0-5 days after participant enrollment.
Secondary outcomes (1)
Top choice diagnosis accuracy score
The secondary outcome will measure participants' performance in identifying the most likely diagnosis for each clinical vignette. After evaluating each case, participants will select their single most likely diagnosis, which will be scored on a pre-specified Three-Tier Diagnostic Accuracy Scale: 18 points for the most accurate diagnosis, 9 points for a clinically reasonable alternative, and 0 points for an incorrect diagnosis. For each participant, a Top Choice Diagnosis Accuracy Score is calculated as (total points earned ÷ maximum possible points) × 100, yielding a 0-100 % range in which higher scores indicate greater diagnostic accuracy. This percentage score will be compared at the case-level between randomized groups to quantify the impact of automation bias on diagnostic decision-making.
Measured: Assessed at a single time point for each case, during the scheduled diagnostic reasoning evaluation session, which takes place between 0-5 days after participant enrollment.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2026
- Study start17 Jan 2026
- Primary completion25 May 2026
- Study completion26 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DiagnosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The trial will be designed as a randomized, two-arm, single-blind parallel group study.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 72 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lahore University of Management Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ihsan Ayyub Qazi, PhD, Lahore University of Management Sciences
- Investigators
- Ihsan Ayyub Qazi, PhD, Principal investigator, Lahore University of Management Sciences (LUMS)Muhammad Hamad Alizai, PhD, Principal investigator, Lahore University of Management Sciences (LUMS)Muhammad Asadullah Khawaja, MBBS, Principal investigator, King Edward Medical UniversityAli Zafar Sheikh, MBBS, Principal investigator, Lahore General HospitalMuhammad Junaid Akhtar, MBBS, Principal investigator, Children's Hospital, Lahore
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07328815
- Sponsor's protocol ID
- LUMS-IRB-0412/12192025/IAQ-FWA
- Status last verified
- Jun 2026
- First submitted
- 26 Dec 2025
- Last updated
- 25 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning Using Behavioral Nudges
- ClinicalTrials.gov ID
- NCT07328815
- Acronym / sponsor ID
- LUMS-IRB-0412/12192025/IAQ-FWA
- Conditions
- Diagnosis
- Keywords
- clinical reasoning, automation bias, behavioral nudges, computer-assisted diagnosis, large language models
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 72 participants (actual)
- Lead sponsor
- Lahore University of Management SciencesUniversity, hospital or other
- Study start
- 17 Jan 2026 (actual)
- Primary completion
- 25 May 2026 (actual)
- Study completion
- 26 May 2026 (actual)
- First posted
- 9 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this randomized controlled trial is to evaluate whether behavioral nudges can reduce automation bias, the uncritical acceptance of automated output, in physicians using large language models (LLM) like ChatGPT-5.1 for clinical decision-making.
The main question it aims to answer is: Does a dual-mechanism behavioral nudge intervention (baseline accuracy anchoring plus case-specific color-coded confidence signals) reduce physicians' uncritical acceptance of incorrect LLM recommendations?
Researchers will compare physicians who receive LLM recommendations along with a behavioral nudge to those who receive LLM recommendations without the nudge to assess if the nudge reduces automation bias.
Participants will:
- Evaluate six clinical vignettes accompanied by LLM-generated recommendations (half containing deliberate, clinically significant errors).
- Control group: Be able to view LLM recommendations in standard format without the nudge.
- Treatment group: Be able to view ChatGPT's diagnostic accuracy on standard medical datasets as an initial anchor, then receive color-coded confidence signals alongside each recommendation (e.g., red for low confidence).
- Have their responses evaluated by blinded reviewers using an expert-developed assessment rubric to detect uncritical acceptance of erroneous information.
Detailed description
Automation bias represents a critical challenge in modern clinical practice, particularly as artificial intelligence (AI) tools become increasingly embedded in healthcare workflows. This cognitive phenomenon describes the tendency of clinicians to favor suggestions from automated decision-making systems, even when those suggestions are incorrect. As Large Language Models (LLM) such as ChatGPT-5.1 gain traction in medical settings, their potential to reduce errors and improve efficiency must be weighed against a significant concern: these models lack rigorous medical validation and may amplify existing cognitive biases through incorrect or misleading recommendations.
The emergence of automation bias in medical contexts reflects a complex interplay of environmental and psychological factors. Time constraints in high-volume clinical settings create pressure to accept AI-generated recommendations without adequate scrutiny. Financial incentives that prioritize efficiency over thoroughness may further discourage critical evaluation necessary for sound clinical judgment. Cognitive fatigue during extended shifts diminishes physicians' capacity for sustained analytical thinking. These pressures interact with psychological mechanisms including diffusion of responsibility, overconfidence in technological solutions, and cognitive offloading, collectively creating conditions where uncritical acceptance of AI-generated recommendations becomes more likely.
This randomized controlled trial evaluates the effectiveness of a behavioral nudge intervention designed to mitigate automation bias among medical doctors utilizing LLM-generated diagnostic recommendations. The primary objective is to determine whether this intervention improves diagnostic reasoning performance scores when evaluating clinical vignettes that include deliberately flawed LLM recommendations. Secondary objectives include assessing whether physician experience level, gender, and prior LLM experience moderate the intervention's effectiveness, determining differential effectiveness for vignettes across different confidence signals.
This study employs a single-blind, randomized controlled trial with two parallel arms. Participants will be randomly assigned 1:1 to either the intervention or control arm. To eliminate variability from differences in prompting skills, participants will not interact directly with a live LLM interface. Instead, all participants will use a custom-built web platform displaying clinical vignettes with pre-generated LLM recommendations, ensuring identical LLM-generated content for each vignette.
All participants will evaluate six clinical vignettes during a single, proctored session lasting approximately 75 minutes. Three vignettes will contain deliberately introduced clinical reasoning flaws in the LLM recommendations, while three will contain correct recommendations. Vignettes will be presented in randomized order to prevent pattern detection.
Control arm participants will evaluate clinical vignettes with LLM diagnostic recommendations generated by ChatGPT presented in standard, neutral text format without additional contextual information. Intervention arm participants will evaluate the same vignettes alongside a behavioral nudge. This intervention consists of two synchronized cognitive cues: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the interface panel, explicitly anchoring expectations to the model's fallibility, and (2) a selective attention cue displaying the LLM recommendation alongside a color-coded confidence signal generated through an ensemble assessment: three independent state-of-the-art LLMs (Claude Sonnet 4.5, Gemini 2.5 Pro Thinking, and GPT-5.1) each provide confidence ratings for the recommendation, and the mean confidence determines the signal color to mitigate single-model miscalibration.
The color-coded confidence signals are categorized into three distinct levels based on the ensemble's mean confidence relative to baseline diagnostic accuracy. Red signals are triggered when the mean confidence falls below ChatGPT's established baseline accuracy, explicitly flagging high-uncertainty cases that demand heightened critical scrutiny. Orange signals indicate that while the mean confidence exceeds the baseline average, it remains below 100%, signaling the need for continued clinical vigilance and the avoidance of complacency. Finally, green signals are reserved for instances of 100% ensemble consensus; however, even at this level of confidence, standard AI safety warnings remain present to guard against over-reliance on the system's output.
Participants will be presented with six clinical vignettes specifically designed to measure automation bias, sourced and modified from real cases representing a range of diagnostic difficulty and common medical specialties. Each vignette follows a standardized format including chief complaint, history of present illness, relevant past medical/social/family history, physical examination findings, and initial laboratory results.
The primary outcome is the Diagnostic Reasoning Performance Score, a composite percentage score based on a structured rubric evaluating: quality of differential diagnoses, supporting findings, opposing findings, final diagnosis accuracy, and appropriateness of next steps. Secondary outcomes include top-choice diagnosis accuracy (incorrect, partially correct, or correct). All responses will be evaluated by blinded reviewers using the assessment rubric.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- The trial will be designed as a randomized, two-arm, single-blind parallel group study.
| Arm | Type | Receives |
|---|---|---|
| ChatGPT Recommendations alongside a Behavioral Nudge | Active comparator | Other: Behavioral Nudge InterventionParticipants will evaluate six clinical vignettes. During the trial, they will have access to clinical recommendations from a specific, commercially available LLM (ChatGPT) in addition to conventional diagnostic resources. LLM recommendations for three vignettes will contain deliberately flawed diagnostic information and for three vignettes it will contain accurate recommendations). The cases will be presented in random order. Participants in this arm will receive a behavioral nudge embedded in the LLM recommendations interface that presents two synchronized cognitive cues when the LLM panel is expanded: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the panel to set realistic expectations before cue intervention located immediately below, which shows the LLM recommendations alongside a case-specific color-coded confidence signal. |
| ChatGPT Recommendations without a Behavioral Nudge | No intervention | –Participants will evaluate six clinical vignettes. During the trial, they will have access to clinical recommendations from a specific, commercially available LLM (ChatGPT) in addition to conventional diagnostic resources. LLM recommendations for three vignettes will contain deliberately flawed diagnostic information. The cases will be presented in random order. Participants in this arm will not receive any behavioral nudge. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Full or Provisionally Registered Medical Practitioners with the Pakistan Medical and Dental Council (PMDC).
- Completed Bachelor of Medicine, Bachelor of Surgery (MBBS) Exam. The equivalent degree of MBBS in US and Canada is the Doctor of Medicine (MD).
- Participants must have completed a structured training program on the use of ChatGPT (or a comparable large language model), totaling at least 10 hours of instruction. The program must include hands-on practice related to LLM's key aspects, specifically prompt engineering and content evaluation.
Key exclusion criteria (1 listed)
- Any other Registered Medical Practitioners (Full or Provisional) with PMDC (e.g., professionals with Bachelor of Dental Surgery or BDS).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Behavioral Nudge InterventionParticipants in the treatment group will receive a behavioral nudge intervention embedded in the LLM recommendations interface that presents two synchronized cognitive cues when the LLM panel is expanded: (1) an anchoring cue displaying ChatGPT's baseline diagnostic accuracy on standard medical datasets at the top of the panel to set realistic expectations before viewing the specific recommendation, and (2) a selective attention cue located immediately below, which shows the LLM recommendation alongside a case-specific and color-coded confidence signal. This signal is categorized as red when the mean ensemble confidence falls below the established baseline accuracy, flagging high-uncertainty cases that demand critical evaluation; orange when confidence meets or exceeds the baseline but remains below 100%, intended to prevent complacency and maintain active clinical scrutiny; and green for a 100% ensemble consensus, though standard cautionary warnings still apply to guard against. | Other | ChatGPT Recommendations alongside a Behavioral Nudge |
Primary outcome
Diagnostic reasoning accuracy score
Time frame: Assessed at a single time point for each case, during the scheduled diagnostic reasoning evaluation session, which takes place between 0-5 days after participant enrollment.
The primary outcome will be the percent correct for each case, ranging from 0 to 100%, where higher scores indicate better diagnostic performance. For each case, participants will be asked for their three leading diagnoses, findings that support each diagnosis, and findings that oppose each diagnosis. For each plausible diagnosis, participants will receive 1 point. Findings supporting the diagnosis and findings opposing the diagnosis will also be graded based on correctness, with 1 point for each correct response. Participants will then be asked to name their top diagnosis they believe is most likely, earning 9 points for a reasonable response and 18 points for the most accurate response. Finally participants will be asked to name up to 3 next steps to further evaluate the patient with 0.5 point awarded for a partially correct response and 1 point for a completely correct response. The primary outcome will be compared at the case-level between the randomized groups.
1 secondary outcome
Top choice diagnosis accuracy score
Time frame: Assessed at a single time point for each case, during the scheduled diagnostic reasoning evaluation session, which takes place between 0-5 days after participant enrollment.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Diagnosis
Not yet recruiting
Effect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High Risk for Obstructive Sleep Apnea Syndrome in High-altitude Regions
Hypoxemia, Gastric Cancer (Diagnosis)
Not yet recruitingPhase 2
Application of Intraperitoneal Hyperthermic Chemotherapy in the Treatment of Gastric Cancer With Peritoneal Metastasis
Gastric Cancer (Diagnosis)
RecruitingObservational study
Clinical Management and Outcomes After Lung Scintigraphy for Suspected Pulmonary Embolism in the Emergency Department
Pulmonary Embolism (Diagnosis)
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingObservational study
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Cancer, Cancer Diagnosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ihsan Ayyub Qazi, PhD principal investigator
Lahore University of Management Sciences (LUMS)
Muhammad Hamad Alizai, PhD principal investigator
Lahore University of Management Sciences (LUMS)
Muhammad Asadullah Khawaja, MBBS principal investigator
King Edward Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Behavioral Nudge Intervention in people with Diagnosis, run by Lahore University of Management Sciences at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Diagnostic reasoning accuracy score (time frame: Assessed at a single time point for each case, during the scheduled diagnostic reasoning evaluation session, which takes place between 0-5 days after participant enrollment.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026; AzTrials last refreshed its copy on 30 Oct 2026.